- Home
- NKTX vs TSI Comparison
NKTX vs TSI Comparison
Compare NKTX & TSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- TSI
- Stock Information
- Founded
- NKTX 2015
- TSI 1987
- Country
- NKTX United States
- TSI United States
- Employees
- NKTX N/A
- TSI N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- TSI Investment Managers
- Sector
- NKTX Health Care
- TSI Finance
- Exchange
- NKTX Nasdaq
- TSI Nasdaq
- Market Cap
- NKTX 225.1M
- TSI 237.0M
- IPO Year
- NKTX 2020
- TSI N/A
- Fundamental
- Price
- NKTX $2.45
- TSI $4.94
- Analyst Decision
- NKTX Strong Buy
- TSI
- Analyst Count
- NKTX 5
- TSI 0
- Target Price
- NKTX $17.00
- TSI N/A
- AVG Volume (30 Days)
- NKTX 1.2M
- TSI 106.8K
- Earning Date
- NKTX 11-07-2024
- TSI 01-01-0001
- Dividend Yield
- NKTX N/A
- TSI 7.46%
- EPS Growth
- NKTX N/A
- TSI N/A
- EPS
- NKTX N/A
- TSI N/A
- Revenue
- NKTX N/A
- TSI N/A
- Revenue This Year
- NKTX N/A
- TSI N/A
- Revenue Next Year
- NKTX N/A
- TSI N/A
- P/E Ratio
- NKTX N/A
- TSI N/A
- Revenue Growth
- NKTX N/A
- TSI N/A
- 52 Week Low
- NKTX $2.38
- TSI $4.48
- 52 Week High
- NKTX $16.24
- TSI $4.87
- Technical
- Relative Strength Index (RSI)
- NKTX 26.80
- TSI 40.88
- Support Level
- NKTX $2.40
- TSI $4.91
- Resistance Level
- NKTX $3.81
- TSI $5.11
- Average True Range (ATR)
- NKTX 0.25
- TSI 0.06
- MACD
- NKTX -0.02
- TSI -0.01
- Stochastic Oscillator
- NKTX 4.90
- TSI 14.29
About NKTX Nkarta Inc.
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.
About TSI TCW Strategic Income Fund Inc.
Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment, and others.